NASDAQ:IBBiShares Nasdaq Biotechnology ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iShares Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $131.94 +0.50 (+0.38 %) (As of 06/5/2020 01:59 PM ET) Add Compare Share Today's Range$130.09Now: $131.94▼$133.0350-Day Range$115.69MA: $128.19▼$134.7452-Week Range$92.15Now: $131.94▼$136.20Volume3.72 million shsAverage Volume3.69 million shsMarket Capitalization$8.79 billionP/E RatioN/ADividend Yield0.20%Beta1.18 ProfileAdvanced ChartDividendFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for iShares Nasdaq Biotechnology ETF. Previous Next 2.5 Community Rank Outperform VotesiShares Nasdaq Biotechnology ETF has received 159 “outperform” votes. (Add your “outperform” vote.)Underperform VotesiShares Nasdaq Biotechnology ETF has received 154 “underperform” votes. (Add your “underperform” vote.)Community SentimentiShares Nasdaq Biotechnology ETF has received 50.80% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about iShares Nasdaq Biotechnology ETF and other stocks. Vote “Outperform” if you believe IBB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IBB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipiShares Nasdaq Biotechnology ETF is a leading dividend payer. It pays a dividend yield of 0.20%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthiShares Nasdaq Biotechnology ETF has only been increasing its dividend for 1 years. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iShares Nasdaq Biotechnology ETF insiders have not sold or bought any company stock.Percentage Held by Institutions72.33% of the stock of iShares Nasdaq Biotechnology ETF is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.03 out of 5 stars Basic Details Issuer BlackRock Fund NameiShares Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$7.70 billion Average Daily Volume$2.62 million Discount/Premium0.08% ETF Expenses Management Fee0.47% Other Expenses0.00% Total Expenses0.47% Fee Waiver0.00% Net Expenses0.47%Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial NASDAQ:IBB Rates by TradingView Receive IBB News and Ratings via Email Sign-up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions How has iShares Nasdaq Biotechnology ETF's stock been impacted by COVID-19 (Coronavirus)? iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IBB stock has increased by 22.7% and is now trading at $131.25. View which stocks have been most impacted by Coronavirus. How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF? iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be paid a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 annualized dividend and a yield of 0.17%. The ex-dividend date is Wednesday, March 25th. View iShares Nasdaq Biotechnology ETF's dividend history. When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work? iShares Nasdaq Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split. Has iShares Nasdaq Biotechnology ETF been receiving favorable news coverage? Media coverage about IBB stock has been trending extremely negative on Friday, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a media sentiment score of -4.2 on InfoTrie's scale. They also gave press coverage about the financial services provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View the latest news aboutiShares Nasdaq Biotechnology ETF. Who are some of iShares Nasdaq Biotechnology ETF's key competitors? Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Hercules Capital (HTGC), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Tortoise Energy Infrastructure (TYG), Boulder Growth & Income Fund (BIF), AllianceBernstein Global Hgh Incm Fd (AWF), Tekla Healthcare Investors (HQH), Blackrock Muniyield Insured Fund (MYI) and General American Investors (GAM). View all competitors. What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Netflix (NFLX), Bank of America (BAC), Tesla (TSLA), Cisco Systems (CSCO), Gilead Sciences (GILD), Micron Technology (MU) and Boeing (BA). Who are iShares Nasdaq Biotechnology ETF's key executives? iShares Nasdaq Biotechnology ETF's management team includes the following people: George G. C. Parker Ph.D., Independent Chairman of the Board of TrusteesMichael Arthur Latham, President, TrusteeJack Gee, Chief Financial Officer, TreasurerGeoffrey D. Flynn, Chief Operating Officer, Executive Vice President, Bio & Compensation - Amy Schioldager, Executive Vice PresidentIra P. Shapiro, Vice President, Chief Legal OfficerMatt Tucker, Vice President, Bio & Compensation - Eilleen M. Clavere, SecretaryCecilia H. Herbert, Independent TrusteeCharles A. Hurty, Independent Trustee What is iShares Nasdaq Biotechnology ETF's stock symbol? iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB." Who are iShares Nasdaq Biotechnology ETF's major shareholders? iShares Nasdaq Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Morgan Stanley (8.58%), JPMorgan Chase & Co. (2.20%), Healthcare of Ontario Pension Plan Trust Fund (1.47%), PNC Financial Services Group Inc. (0.87%), Advisor Group Holdings Inc. (0.63%) and Commerce Bank (0.60%). Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock? IBB stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, SG Americas Securities LLC, Baker Avenue Asset Management LP, Cavalier Investments LLC, Deutsche Bank AG, Bourgeon Capital Management LLC, CAPROCK Group Inc., and Raymond James & Associates. Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock? IBB stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Advisor Group Holdings Inc., Morgan Stanley, Commerce Bank, Sandler Capital Management, Oakworth Capital Inc., Wellington Management Group LLP, and QVT Financial LP. How do I buy shares of iShares Nasdaq Biotechnology ETF? Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is iShares Nasdaq Biotechnology ETF's stock price today? One share of IBB stock can currently be purchased for approximately $131.25. How big of a company is iShares Nasdaq Biotechnology ETF? iShares Nasdaq Biotechnology ETF has a market capitalization of $8.74 billion. This page was last updated on 6/5/2020 by MarketBeat.com Staff
